Why Aurinia's Stock Is Trading Lower Today

Aurinia Pharmaceuticals AUPH shares are trading lower on Thursday.

In an SEC filing on Wednesday night, the company announced it and Lonza have entered an exclusive agreement for a dedicated Voclosporin Manufacturing Capacity. The Monoplant is estimated to be operational in 2023.

Aurinia Pharmaceuticals shares were trading down 13.22% at $13.16 on Thursday at the time of publication. The stock has a 52-week high of $21.93 and a 52-week low of $9.83.